Library — CHDR

Search

Filter

Physical activity and the association with sporadic ALS.

Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH

Neurology, 2005 Jan; 64(2):241-5

View publication
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis.

Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH, van der Luyt J, Wokke JH, Van den Berg LH

Journal of neurology, neurosurgery, and psychiatry, 2007 Mar; 78(4):367-71

View publication
Alternative trial design in amyotrophic lateral sclerosis saves time and patients.

Groeneveld GJ, Graf M, van der Tweel I, van den Berg LH, Ludolph AC

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2007 Sep; 8(5):266-9

View publication
The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome).

Posner J, Cohen AF, Land G, Winton C, Peck AW

British journal of clinical pharmacology, 1989 Jun; 28(1):117-20

View publication
Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.

Groeneveld GJ, van Kan HJ, Toraño JS, Veldink JH, Guchelaar HJ, Wokke JH, van den Berg LH

Journal of the neurological sciences, 2001 Oct; 191(1-2):121-5

View publication
[Diagnostic image (162) A woman with temporary hemiplegia. Temporary embolic occlusion of the left middle cerebral artery by a thrombus].

Groeneveld GJ, van der Schaaf IC

Nederlands tijdschrift voor geneeskunde, 2003 Oct; 147(43):2123

View publication
Few adverse effects of long-term creatine supplementation in a placebo-controlled trial.

Groeneveld GJ, Beijer C, Veldink JH, Kalmijn S, Wokke JH, van den Berg LH

International journal of sports medicine, 2005 Apr; 26(4):307-13

View publication
Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.

van Kan HJ, van den Berg LH, Groeneveld GJ, van der Straaten RJ, van Vught PW, Lie-A-Huen L, Guchelaar HJ

Biopharmaceutics & drug disposition, 2008 Mar; 29(3):139-44

View publication
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Wirtz PW, Verschuuren JJ, van Dijk JG, de Kam ML, Schoemaker RC, van Hasselt JG, Titulaer MJ, Tjaden UR, den Hartigh J, van Gerven JM

Clinical pharmacology and therapeutics, 2009 Jun; 86(1):44-8

View publication

«
1
2
3
4
5
6
7
8
...
13
14
»